focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Venture

16 Jan 2007 07:01

Amphion Innovations PLC16 January 2007 Amphion Innovations, plc Creation of a Gulf-based Joint Venture 16 January 2007, London, UK - Amphion Innovations plc ("Amphion"), a builder ofcompanies in life sciences and technology, today announces that it has signed aHeads of Agreement with a Gulf-based investment company, MS Holdings, backed bythe Al-Sayer and Al-Mutawa families of Kuwait, to create a Gulf-based jointventure, MSA Investors ("MSA"). The Gulf Cooperation Council countries of the Arabian Gulf now represent thefastest growing economy after China and India. Building on Amphion'scompany-building strategy and its long-standing ties to the region, the jointventure's objective will be to create new markets and strategic partnerships forAmphion's Partner Companies, identify new investment opportunities in the regionin areas of particular Amphion expertise and provide strong access to capitaland opportunities from both existing and new Gulf investors. Under the Heads of Agreement, Amphion commits to the formation and incorporationof MSA and to the establishment and operation of two additional companies to bemanaged by MSA, Saydanah and Suvani. Amphion's Gulf partners have committedUS$1 million to the creation of these companies and additional investment upontheir completion. Saydanah is being established by our partners in the region in order to bring "functional foods" to a sizeable and wealthy Arab market. Saydanah will be builtupon Amphion's experience and expertise in the field of nutrigenomics, a sciencethat identifies foods that alter gene expression for better health, through itsPartner Company, WellGen. Suvani, which has previously been incorporated by Amphion, is currentlyproviding skilled software and technology support services from India to AmphionPartner Companies, Motif and FireStar. Under the Heads of Agreement, Suvaniwill be merged with a Gulf-based radio frequency identification company (RFID),to be developed by MSA, with the aim of servicing a growing Gulf RFID market.It is expected that the new company will acquire an exclusive right todistribute the products in the Gulf of Amphion's Partner Company, Axcess, aleading RFID company. The Gulf partners have committed to provide an additional US$3.5 million to fundthe further development of MSA and its companies upon their formation. Amphionwill also transfer 500,000 shares in Motif to MSA in return for a 50% interestin the new Company. Following its initial capitalization, MSA will have anestimated enterprise value of $10 million. MSA is expected to be formed no later than 1 March 2007. In the event that MSAis not formed, then MSA shall invest the US$1 million by way of subscribing for166,667 shares in Motif, and investing US$500,000 in the Gulf-based companies tobe formed by Amphion in the future. Richard C.E. Morgan Amphion's Chief Executive Officer states: "The last several years have seen dramatic economic development in the Gulf,which has been matched by rapid growth in the region's capital markets. Whilethe region is relatively rich in capital and in talented people, there is littleexperience of building companies based on cutting edge technology. WithAmphion's 20 year history and track record of investment and close relationshipsin the Gulf region, we look forward to bringing our core strategy of buildingstrong companies with solid intellectual property to the Gulf." For further information please contact: Amphion Innovations plcJosh Berkman, Media Relations +1 (646) 747 7158 Financial Dynamics +44 207 269 7169John Gilbert About Amphion Innovations plc Amphion Innovations plc is listed on the AIM Exchange in London under the symbolAMP. Amphion's business is the formation, financing, management and developmentof life sciences and technology companies, primarily in the US and UK, workingin partnership with corporations, governments, universities and entrepreneursseeking to commercialize their intellectual property. Amphion's management teamhas built more than 30 companies in 20 years, all of which have achieved valuein excess of $120 million. On the web: www.amphionplc.com About Motif BioSciences, Inc. Motif BioSciences is a population genetics company focused on discovering genescausing common diseases by utilising human genetic data from the Persian/ArabianGulf region. Motif is headquartered in the US and London, with additionaloperations in the Gulf region to develop epidemiological, genealogical andgenetic information. On the web: www.motifbio.com About WellGen, Inc. WellGen, Inc., based in New Brunswick, NJ, is a biotechnology company that isdiscovering and developing products for food, therapeutics, and dietarysupplement markets. WellGen's technical platform is a method of screening theeffect of food and related substances on the expression of genes associated withhuman health conditions. The company has developed proprietary substances thathelp reduce risk and severity for a variety of diseases. On the web: www.wellgen.com About AXCESS International Inc. AXCESS International Inc. (OTCBB:AXSI), headquartered in greater Dallas, TX,provides Enterprise DotTM, Dual-ActiveTM RFID (radio frequency identification)and Real Time Location Systems (RTLS) for asset management, physical security,sensing and supply chain efficiencies. The battery-powered (active) RFID tagslocate, identify, track, monitor, count, and protect people, assets, inventory,and vehicles. The patented technology enables applications including: automatic"hands-free" personnel access control, automatic vehicle access control andlogistics management, automatic asset management, and sensor management. AXCESSis a portfolio company of Amphion Innovations plc. On the web: www.axcessinc.com About FireStar Software, Inc. FireStar is the provider of EdgeNode, the leading InterEnterprise Service Bussoftware product for building software applications that automate the exchangeof business transactions between companies that are business partners - buyers,sellers, suppliers, vendors, manufacturers, and distributors. FireStar'sEdgeNode expands the market for these InterEnterprise Transaction Applicationsby directly addressing key obstacles to broader adoption at a significantlylower price point than alternative approaches. On the web: www.firestarsoftware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jul 20155:07 pmRNSHolding(s) in Company
23rd Jun 20158:47 amRNSPartner Company raises £22 million
23rd Jun 20157:00 amRNSPreliminary Results
5th Jun 20157:00 amRNSPlacing to raise £1.54 million
19th May 20152:35 pmRNSAppointment of broker
15th Apr 20157:01 amRNSFDA Results
7th Apr 20157:00 amRNSShares Issued for Exercised Warrants
2nd Apr 20157:01 amRNSFirst Day of Dealings of Amphion Partner Company
24th Mar 20153:28 pmRNSIssue of Shares
20th Mar 20157:01 amRNSMotif Bio Ltd Update Re Intention to Float
26th Feb 20157:00 amRNSIssue of Equity
9th Feb 20157:00 amRNSDirector/PDMR Shareholding
2nd Feb 20154:18 pmRNSReissue: Partner Company's Intention to Float
2nd Feb 20158:00 amRNSPartner Company's Intention to Float on AIM
22nd Jan 20151:15 pmRNSDirector/PDMR Shareholding
19th Jan 20157:00 amRNSLandmark Acquisition & Update by Partner Company
6th Jan 20157:00 amRNSDataTern Receives Favourable Appeal Ruling
24th Sep 20147:00 amRNSDirectors' Dealings
19th Sep 20147:00 amRNSHalf Yearly Report
9th Sep 20147:00 amRNSAdditional Draws on Loan Facility
28th Aug 20147:00 amRNSDirectorate Change
7th Aug 20144:51 pmRNSResult of AGM and EGM
10th Jul 20149:10 amRNSDirectors' Dealings
8th Jul 20147:00 amRNSAmphion Partner Motif Can Help Solve Health Crisis
20th Jun 20147:00 amRNSNotice of EGM
18th Jun 20147:00 amRNSFinal Results
5th Jun 20147:00 amRNSNew Loan Facility
14th Apr 20147:00 amRNSAppeal Ruling
7th Apr 20145:03 pmRNSDirector/PDMR Shareholding
28th Jan 20147:00 amRNSConvertible Promissory Note Extension
12th Dec 20137:00 amRNSUpdate on Covertible Promissory Note
13th Nov 20134:33 pmRNSDirector/PDMR Shareholding
13th Nov 20137:00 amRNSPartner Company Update
16th Oct 20137:02 amRNSPartner Company IPO
24th Sep 20137:00 amRNSHalf Yearly Report
12th Sep 20137:02 amRNSPartner company Kromek seeks IPO on AIM
13th Aug 20135:16 pmRNSResult of AGM
1st Jul 201312:02 pmRNSDirector/PDMR Shareholding
28th Jun 20137:00 amRNSFinal Results
18th Apr 20137:00 amRNSDirector/PDMR Shareholding
17th Apr 20137:00 amRNSTrading Statement
28th Mar 20137:02 amRNSChange of Adviser
19th Dec 20127:00 amRNSHolding(s) in Company
13th Dec 20127:00 amRNSFundraising
5th Dec 20127:00 amRNSAmphion announces new partnership with Motif
3rd Oct 20127:00 amRNSDirector/PDMR Shareholding
28th Sep 20124:24 pmRNSDirector/PDMR Shareholding
19th Sep 20127:00 amRNSHalf Yearly Report
29th Aug 20127:00 amRNSUpdate - patent litigation
27th Jul 20127:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.